Mike E. Pape
President bij Orchard Venture Partners
Profiel
Mike E.
Pape is the founder of Esperion Therapeutics, Inc. (founded in 1998), Base4 Biotechnology, Inc. (founded in 2009), and Akebia Therapeutics, Inc. (founded in 2007).
He held the title of Chief Executive & Scientific Officer at Base4 Biotechnology, Inc. from 2009 to 2012.
Dr. Pape currently holds positions at Michigan Biosciences Industry Association as a member of the Board of Directors, at Apjohn Ventures LLC as a Scientific Advisor, and at Orchard Venture Partners as a Founding Partner.
In the past, Dr. Pape worked as a Director at Sierra Oncology, Inc., as a Scientist at Pfizer Inc., as a Scientist at The Upjohn Co., and as a Scientist at Parke-Davis Pharmaceuticals Ltd.Dr. Pape obtained a doctorate degree from Purdue University, an undergraduate degree from the University of Michigan, and an MBA from The University of Chicago Booth School of Business.
Actieve functies van Mike E. Pape
| Bedrijven | Functie | Begin |
|---|---|---|
Orchard Venture Partners
 Orchard Venture Partners Investment ManagersFinance Orchard Venture Partners (Orchard Venture Partners) is a venture capital subsidiary of Orchard Capital Management LLC founded in 2004. The firm is headquartered in Illinois. | President | 01-01-2005 |
Apjohn Ventures LLC
 Apjohn Ventures LLC Investment ManagersFinance Apjohn Ventures LLC (Apjohn Ventures) is a venture capital subsidiary of Apjohn Group LLC founded in 2002 by Mina Patel Sooch and Donald R Parfet. The firm is headquartered in Kalamazoo, Michigan. | Consultant / Adviseur | - |
Michigan Biosciences Industry Association
 Michigan Biosciences Industry Association Miscellaneous Commercial ServicesCommercial Services The Michigan Biosciences Industry Association is an official bio-industry association that serves various sectors such as pharmaceutical, medical device, ag-bio, r&d, health IT, and life science logistics. The company is based in Ann Arbor, MI. The association provides cost-savings on business essentials, industry connections and networking, talent support, advocacy, and more. The CEO of the company is Stephen Rapundalo. | Directeur/Bestuurslid | - |
Eerdere bekende functies van Mike E. Pape
| Bedrijven | Functie | Einde |
|---|---|---|
Base4 Biotechnology, Inc.
 Base4 Biotechnology, Inc. Pharmaceuticals: MajorHealth Technology Nymirum, Inc. is a biotechnology company that aims to unlock the potential of RNA with small molecules to advance transformative medicine. The company is based in Ann Arbor, MI. The company's subsidiary, Base4 Biotechnology, is developing RNA-modulating small molecule drugs using their next-generation structure-based RNA platform. Nymirum was founded in 2009 by Mike E. Pape, Joshua Paul Fairbank, Hashim M. Al-Hashimi, and Andrew C. Stelzer. | Algemeen Directeur | - |
| Parke-Davis Pharmaceuticals Ltd. | Corporate Officer/Principal | - |
| SIERRA ONCOLOGY, INC. | Directeur/Bestuurslid | - |
| AKEBIA THERAPEUTICS, INC. | Oprichter | - |
| ESPERION THERAPEUTICS, INC. | Oprichter | - |
Opleiding van Mike E. Pape
| Purdue University | Doctorate Degree |
| University of Michigan | Undergraduate Degree |
| The University of Chicago Booth School of Business | Masters Business Admin |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 3 |
|---|---|
| PFIZER, INC. | Health Technology |
| ESPERION THERAPEUTICS, INC. | Health Technology |
| AKEBIA THERAPEUTICS, INC. | Health Technology |
| Bedrijven in privébezit | 7 |
|---|---|
| The Upjohn Co. | Health Technology |
Sierra Oncology, Inc.
 Sierra Oncology, Inc. BiotechnologyHealth Technology Sierra Oncology, Inc. was a clinical stage drug development company of therapeutics for the treatment of cancer. The firm focused on advanced targeted therapeutics for the treatment of patients with significant unmet medical needs in hematology and oncology. Its product Momelotinib, a selective and orally-bioavailable JAK1, JAK2 & ACVR1 inhibitor with a differentiated therapeutic profile in myelofibrosis encompassing robust constitutional symptom improvements. The company was founded in May 2003 and is headquartered in San Mateo, CA. | Health Technology |
Base4 Biotechnology, Inc.
Base4 Biotechnology, Inc. Pharmaceuticals: MajorHealth Technology Nymirum, Inc. is a biotechnology company that aims to unlock the potential of RNA with small molecules to advance transformative medicine. The company is based in Ann Arbor, MI. The company's subsidiary, Base4 Biotechnology, is developing RNA-modulating small molecule drugs using their next-generation structure-based RNA platform. Nymirum was founded in 2009 by Mike E. Pape, Joshua Paul Fairbank, Hashim M. Al-Hashimi, and Andrew C. Stelzer. | Health Technology |
Apjohn Ventures LLC
Apjohn Ventures LLC Investment ManagersFinance Apjohn Ventures LLC (Apjohn Ventures) is a venture capital subsidiary of Apjohn Group LLC founded in 2002 by Mina Patel Sooch and Donald R Parfet. The firm is headquartered in Kalamazoo, Michigan. | Finance |
Orchard Venture Partners
Orchard Venture Partners Investment ManagersFinance Orchard Venture Partners (Orchard Venture Partners) is a venture capital subsidiary of Orchard Capital Management LLC founded in 2004. The firm is headquartered in Illinois. | Finance |
Michigan Biosciences Industry Association
Michigan Biosciences Industry Association Miscellaneous Commercial ServicesCommercial Services The Michigan Biosciences Industry Association is an official bio-industry association that serves various sectors such as pharmaceutical, medical device, ag-bio, r&d, health IT, and life science logistics. The company is based in Ann Arbor, MI. The association provides cost-savings on business essentials, industry connections and networking, talent support, advocacy, and more. The CEO of the company is Stephen Rapundalo. | Commercial Services |
| Parke-Davis Pharmaceuticals Ltd. |
